Systems biology of vaccination for seasonal influenza in humans

Nature Immunology

Volumn 12, Issue 8, 2011, Pages 786-795

  Nakaya, Helder I ^a   Wrammert, Jens ^a,b   Lee, Eva K ^c   Racioppi, Luigi ^d,e   Marie Kunze, Stephanie ^a   Haining, W Nicholas ^f   Means, Anthony R ^e   Kasturi, Sudhir P ^a   Khan, Nooruddin ^a   Li, Gui Mei ^a,b   McCausland, Megan ^a,b   Kanchan, Vibhu ^a,b   Kokko, Kenneth E ^b   Li, Shuzhao ^a   Elbein, Rivka ^b   Mehta, Aneesh K ^b   Aderem, Alan ^g   Subbarao, Kanta ^h   Ahmed, Rafi ^a,b   Pulendran, Bali ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Georgia Institute of Technology   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; INFLUENZA VACCINE; LIVE VACCINE;

ADAPTIVE IMMUNITY; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEASONAL INFLUENZA; SYSTEMS BIOLOGY;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; GENE EXPRESSION PROFILING; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, INNATE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; ORTHOMYXOVIRIDAE; SEASONS; SYSTEMS BIOLOGY; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 80051989398     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2067     Document Type: Article

References (54)

1. Sasaki, S. et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81, 215-228 (2007). (Pubitemid 44975162)
2. Fiore, A.E. et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm. Rep. 59, 1-62 (2010).
3. Sasaki, S. et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS ONE 3, e2975 (2008).
4. Zeman, A.M. et al. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr. Infect. Dis. J. 26, 107-115 (2007). (Pubitemid 46183359)
5. Pulendran, B., Li, S. & Nakaya, H.I. Systems vaccinology. Immunity 33, 516-529 (2010).
6. Querec, T.D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116-125 (2009).
7. Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131 (2008).
8. Pulendran, B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9, 741-747 (2009).
9. Monath, T.P. Yellow fever vaccine. Expert Rev. Vaccines 4, 553-574 (2005). (Pubitemid 41297302)
10. Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413-424 (2006). (Pubitemid 43290850)
11. Barrett, A.D. & Teuwen, D.E. Yellow fever vaccine-how does it work and why do rare cases of serious adverse events take place? Curr. Opin. Immunol. 21, 308-313 (2009).
12. Johnson, P.R. Jr. Feldman, S., Thompson, J.M., Mahoney, J.D. & Wright, P.F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J. Med. Virol. 17, 325-335 (1985). (Pubitemid 16202801)
13. Beyer, W.E., Palache, A.M., de Jong, J.C. & Osterhaus, A.D. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 20, 1340-1353 (2002). (Pubitemid 34131675)
14. US Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines (Office of Communication, Training and Manufacturers Assistance, Rockville, Maryland, 2007).
15. Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667-671 (2008). (Pubitemid 351769295)
16. Takaoka, A. & Yanai, H. Interferon signalling network in innate defence. Cell. Microbiol. 8, 907-922 (2006). (Pubitemid 43670834)
17. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001). (Pubitemid 32397092)
18. Iwakoshi, N.N. et al. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4, 321-329 (2003). (Pubitemid 36432313)
19. Iwakoshi, N.N., Lee, A.H. & Glimcher, L.H. The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response. Immunol. Rev. 194, 29-38 (2003). (Pubitemid 36886426)
20. Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519-529 (2007). (Pubitemid 46985379)
21. Ueda, Y. et al. Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum. Immunol. 64, 1144-1151 (2003). (Pubitemid 37475275)
22. Shen-Orr, S.S. et al. Cell type-specific gene expression differences in complex tissues. Nat. Methods 7, 287-289 (2010).
23. Avery, D.T. et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112, 286-297 (2003). (Pubitemid 38056364)
24. Park, S.W. et al. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat. Med. 16, 429-437 (2010).
25. Liu, B. & Li, Z. Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin. Blood 112, 1223-1230 (2008).
26. Apostolou, A., Shen, Y., Liang, Y., Luo, J. & Fang, S. Armet, a UPR-upregulated protein, inhibits cell proliferation and ER stress-induced cell death. Exp. Cell Res. 314, 2454-2467 (2008).
27. Huleatt, J.W. et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26, 201-214 (2008). (Pubitemid 50008089)
28. Treanor, J.J. et al. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine 28, 8268-8274 (2010).
29. Talbot, H.K. et al. Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin. PLoS ONE 5, e14442 (2010).
30. He, X.S. et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J. Virol. 80, 11756-11766 (2006).
31. Le Bon, A. et al. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176, 2074-2078 (2006). (Pubitemid 43201653)
32. Lee, E.K. Large-scale optimization-based classification models in medicine and biology. Ann. Biomed. Eng. 35, 1095-1109 (2007). (Pubitemid 46828718)
33. Brooks, J.P. & Lee, E.K. Analysis of the consistency of a mixed integer programming-based multi-category constrained discriminant model. Ann. Oper. Res. 174, 147-168 (2010).
34. Sullivan, S.J., Jacobson, R. & Poland, G.A. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Rev. Vaccines 9, 1127-1133 (2010).
35. Anderson, K.J. & Allen, R.L. Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells. Immunology 127, 8-17 (2009).
36. Thomas, R., Matthias, T. & Witte, T. Leukocyte immunoglobulin-like receptors as new players in autoimmunity. Clin. Rev. Allergy Immunol. 38, 159-162 (2010).
37. Brown, D., Trowsdale, J. & Allen, R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64, 215-225 (2004). (Pubitemid 39120446)
38. Krebs, J., Wilson, A. & Kisielow, P. Calmodulin-dependent protein kinase IV during T-cell development. Biochem. Biophys. Res. Commun. 241, 383-389 (1997). (Pubitemid 28020110)
39. Wang, S.L., Ribar, T.J. & Means, A.R. Expression of Ca2+/calmodulin-dependent protein kinase IV (caMKIV) messenger RNA during murine embryogenesis. Cell Growth Differ. 12, 351-361 (2001). (Pubitemid 32685636)
40. Anderson, K.A. & Means, A.R. Defective signaling in a subpopulation of CD4+ T cells in the absence of Ca2+/calmodulin-dependent protein kinase IV. Mol. Cell. Biol. 22, 23-29 (2002). (Pubitemid 33144253)
41. Illario, M. et al. Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. Blood 111, 723-731 (2008).
42. Sato, K. et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12, 1410-1416 (2006). (Pubitemid 44924500)
43. Kitsos, C.M. et al. Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance. J. Biol. Chem. 280, 33101-33108 (2005). (Pubitemid 41397105)
44. Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat. Immunol. 131, 509-517 (2011).
45. Moldoveanu, Z., Clements, M.L., Prince, S.J., Murphy, B.R. & Mestecky, J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13, 1006-1012 (1995).
46. Shubinsky, G. & Schlesinger, M. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity 7, 315-324 (1997). (Pubitemid 27446006)
47. Deaglio, S., Mehta, K. & Malavasi, F. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk. Res. 25, 1-12 (2001). (Pubitemid 32012975)
48. Clements, M.L., Betts, R.F., Tierney, E.L. & Murphy, B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24, 157-160 (1986). (Pubitemid 16090261)
49. Potter, C.W. & Oxford, J.S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35, 69-75 (1979). (Pubitemid 9096975)
50. Hirota, Y. et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 15, 962-967 (1997). (Pubitemid 27308571)
51. Belshe, R.B. Current status of live attenuated influenza virus vaccine in the US. Virus Res. 103, 177-185 (2004). (Pubitemid 38649077)
52. Chen, G.L., Lamirande, E.W., Jin, H., Kemble, G. & Subbarao, K. Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398, 109-114 (2010).
53. Crotty, S. et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171, 4969-4973 (2003). (Pubitemid 37432774)
54. Wu, J.Y. et al. Spermiogenesis and exchange of basic nuclear proteins are impaired in male germ cells lacking Camk4. Nat. Genet. 25, 448-452 (2000). (Pubitemid 32983441)